Skip to main content
. 2008 Apr 20;23(2):270–277. doi: 10.3346/jkms.2008.23.2.270

Fig. 4.

Fig. 4

Differences in methylation status of MGMT and p16 in tumors of patients with a family history of colorectal cancer and in those with sporadic colorectal cancer. Compared with sporadic colorectal cancers, MGMT was more frequently (p=0.016) and p16 was less frequently (p=0.046) methylated in colorectal cancers from patients with a family history.